| 发明名称 |
Use of NR2B-selective NMDA-receptor antagonists for the treatment of ophthalmic diseases |
| 摘要 |
The invention is directed to the use of improved NR2B antagonists for the prevention and treatment of retinal or optic nerve head damage in mammals. Compositions and methods are disclosed.
|
| 申请公布号 |
US6291479(B1) |
申请公布日期 |
2001.09.18 |
| 申请号 |
US19990452004 |
申请日期 |
1999.11.30 |
| 申请人 |
ALCON MANUFACTURING, LTD. |
发明人 |
SHARIF NAJAM |
| 分类号 |
A61K9/00;A61K31/4418;A61K31/445;A61P27/06;(IPC1-7):A67K31/445 |
主分类号 |
A61K9/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
